VLCC Health Care Annual Report

VLCC Health Care Limited (VLCC) Return Comparision with Primex 40 Index

Periods	1 Week	1 Month	3 Months	6 Months	1 Year	3 Years	All Time
Primex-40
VLCC Health Care Limited

VLCC Health Care Limited Balance Sheet (Rs in Lakhs)

Particulars	31 March 2021	31 March 2020
ASSETS
Non-current assets
Property, plant and equipment	25,116.00	28,078.00
Capital work-in-progress	482	295
Goodwill	1933	1916
Other intangible assets	257	366
Right-of-use-assets	17472	21398
Loans	874	706
Other financial assets	338	720
Income tax assets (Net)	324	472
Deferred tax assets (Net)	5,264.00	4,917.00
Other non-current assets	88.00	69.00
Current assets
Inventories	5,719.00	7,352.00
Trade receivables	4,686.00	3,474.00
Loans	980.00	1,218.00
Cash and cash equivalents	3834	1214
Other financial assets	82	149
Other current assets	1785	2789
TOTAL ASSETS	69,234.00	75,133.00
EQUITY AND LIABILITIES
Equity share capital	3,767.00	3,767.00
Other equity	4,207.00	3,732.00
Non- controllable interests	-367.00	-407.00
Non-current liabilities
Contract liabilities	860	1004
Borrowings	5055	5324
Lease liabilities	14578	16089
Other financial liabilities	203	207
Provisions	1,127.00	1255
Current liabilities
Contract liabilities	7614	6467
Borrowings	5,096.00	6,259.00
Lease liabilities	5,109.00	6,641.00
Total outstanding dues of micro and small enterprises	241.00	253.00
Total outstanding dues of creditors other than micro and small enterprises	16,106.00	19,379.00
Other financial liabilities	3,784.00	3,769.00
Provisions	892.00	487.00
Other current liabilities	962.00	907.00
TOTAL EQUITY AND LIABILITIES	69,234.00	75,133.00

VLCC Health Care Limited Profit & Loss Statement (Rs in Lakhs)

PARTICULARS	31 March 2021	31 March 2020
Revenue from operations	53,292.00	76,957.00
Other income	3119	413
Total income	56,411.00	77,370.00
Cost of Material Consumed	9,762.00	13,187.00
Purchase of stock in trade	886	1,259.00
Changes in inventories of stock in trade	861	-954.00
Employee benefits expense	17,078.00	25,313.00
Other expenses	12,925.00	23,909.00
Total expenses	41,512.00	62,714.00
Earnings before interest, tax, depreciation and amortisation	14,899.00	14,656.00
Finance Income	113.00	133.00
Finance costs	4,585.00	5,443.00
depreciation and amortisation expenses	9,913.00	10,672.00
Profit/(Loss) before tax and exceptional items	514.00	-1,326.00
Exceptional items	-	327.00
Profit/(Loss) before tax and after exceptional items	514.00	-1,653.00
Current tax	214	230
Adjustments of tax relating to earlier years	22	-
Deferred tax credit	-346	-353
Profit/(Loss) for the year	624.00	-1,531.00
Re-measurements losses on defined benefit plans	-128	-23
Income tax credit	1	-
Exchanges differences on translation of foreign operations	17	309
Other comprehensive income/(loss) for the year	-110	286
Total comprehensive income/(loss) for the year	514.00	-1,245.00
Basic and diluted earnings per equity share (in INR)	-5.3	1.48
Profit/(Loss) for the year after tax
Attributable to:
Equity holders of parent	612	-1540
Non controllable interest	12	9
Other comprehensive income/(loss) for the year
Attributable to:
Equity holders of parent	-138	318
Non controllable interest	28	-32
Total comprehensive income/(loss) for the year
Attributable to:
Equity holders of parent	502	-1254
Non controllable interest	12	9
Earnings/ (loss) per share (INR)
Basic	1.63	-4.09
Diluted	1.62	-4.09

VLCC Health Care Limited Consolidated Cash Flow Statement (Rs in Lakhs)

Particulars	31 March 2021	31 March 2020
Cash flows from operating activities
Profit / (Loss) before tax and after exceptional items	514.00	-1,654.00
Adjustments for:
Depreciation and amortisation	9,913.00	10,672.00
Impairment of Goodwill	-	79.00
Allowances for doubtful trade receivables	1,183.00	1,139.00
Allowances for doubtful Advances	77.00	31.00
Provision for doubtful trade receivables written back	-26.00	-
Liabilities written back	-433.00	-3.00
Provision for inventories	477.00	874.00
provision for decommissioning liabilities	7.00	7.00
Loss on sale of property, plant and equipment	13.00	36.00
Finance costs	4,585.00	5,443.00
Lease concessions	-2,221.00	-
Gain on derecognition of lease liability	-208.00	-
Finance income	-113.00	-133.00
Unrealised foreign exchange (gain) / loss	-10.00	30.00
Operating profit before working capital changes	13,758.00	16,521.00
Decrease in trade payables and other liabilities	-2,472.00	-2,131.00
Increase/(decrease) in other liabilities	1,110.00	-1,526.00
Increase/(decrease) provisions	169.00	-227.00
(Increase)/decrease in trade receivables, loans and other financial assets	-2,337.00	853.00
(Increase)/decrease in inventories	1,101.00	-1,475.00
(Increase)/decrease in other assets	906.00	-125.00
Cash generated by operations	12,234.00	11,890.00
Direct taxes (paid)/Refund	-88.00	-172
Net cash generated by operating activities	12,147.00	11,718.00
Cash flows from investing activities
Proceeds from sale of property, plant and equipment	95.00	91.00
Purchase of PPE including capital advance	-1,830.00	-2,718.00
Interest received	36.00	127.00
(Investments)/ proceeds from bank deposits	449.00	-600.00
Net cash used in investing activities	-1,250.00	-3,100.00
Cash flows from financing activities
Proceeds from borrowings	1,770.00	4,084.00
Repayments of borrowings	-2,081.00	-5,633.00
Decrease in cash credits (net)	-963.00	-23.00
Payment of principal portion of lease liabilities	-2,469.00	-4,682.00
Interest Paid	-4,534.00	-5,377.00
Net cash generated from financing activities	-8,277.00	-11,631.00
Net increase/(decrease) in cash and cash equivalents during the year	2,620.00	-3,013.00
Cash and cash equivalents at the beginning of the year	1,214.00	4,227.00
Cash and cash equivalents at the end of the year	3,834.00	1,214.00

Here is a summary of the Cash Flow Statement for the years 2021 and 2020:

Operating Activities:

Profit/Loss Before Tax and After Exceptional Items: The company reported a profit of 514.00 in 2021, contrasting with a loss of -1,654.00 in 2020, indicating a significant improvement in profitability.

Adjustments: Various adjustments were made, including depreciation, impairment charges, provisions for doubtful receivables and advances, finance costs, lease concessions, and unrealized foreign exchange gains/losses.

Operating Profit Before Working Capital Changes: Despite adjustments, the operating profit before working capital changes decreased slightly from 16,521.00 in 2020 to 13,758.00 in 2021.

Changes in Working Capital: The company experienced changes in trade payables, other liabilities, provisions, trade receivables, loans, inventories, and other assets, which affected cash flows from operations.

Cash Generated by Operations: The cash generated by operations remained relatively stable, amounting to 12,234.00 in 2021 and 11,890.00 in 2020.

Investing Activities:

Proceeds from Sale of Property, Plant, and Equipment: The company received proceeds from the sale of assets, amounting to 95.00 in 2021 and 91.00 in 2020.

Purchase of Property, Plant, and Equipment (PPE): Investments in PPE decreased from -2,718.00 in 2020 to -1,830.00 in 2021.

Interest Received and Investments: Interest received and investments in bank deposits fluctuated, impacting cash flows from investing activities.

Net Cash Used in Investing Activities: The net cash used in investing activities decreased from -3,100.00 in 2020 to -1,250.00 in 2021, primarily due to reduced investments in PPE.

Financing Activities:

Proceeds and Repayments of Borrowings: The company received proceeds from borrowings, but also made repayments, resulting in a decrease in borrowing activities from 4,084.00 in 2020 to 1,770.00 in 2021.

Decrease in Cash Credits: There was a decrease in cash credits, impacting financing activities negatively.

Payment of Lease Liabilities and Interest Paid: Payments of principal lease liabilities and interest expenses decreased from -5,377.00 in 2020 to -4,534.00 in 2021.

Net Cash Generated from Financing Activities: The net cash generated from financing activities decreased from -11,631.00 in 2020 to -8,277.00 in 2021.

Overall Cash Position:

Net Increase/Decrease in Cash: Despite a loss in cash and cash equivalents in 2020, the company experienced a significant increase in 2021, with a net increase of 2,620.00.

Cash and Cash Equivalents: The company ended 2021 with cash and cash equivalents of 3,834.00, compared to 1,214.00 in 2020, indicating improved liquidity and financial health.

VLCC Health Care Limited Annual Report 2021

Download

VLCC Health Care Ltd Annual Report and Financials

VLCC Health Care Limited (VLCC) Return Comparision with Primex 40 Index

VLCC Health Care Limited Balance Sheet (Rs in Lakhs)

VLCC Health Care Limited Profit & Loss Statement (Rs in Lakhs)

VLCC Health Care Limited Consolidated Cash Flow Statement (Rs in Lakhs)

VLCC Health Care Annual Report

VLCC Health Care Limited Annual Report 2021

Most Searched Unlisted & Pre IPO Companies Stocks in India

HDB Financial

NSE India

BIRA

Capgemini

Hero Fincorp

Nayara Energy

OTIS Elevator

Sterlite Power

Care Health

PharmEasy

Philips India

Hexaware

Vikram Solar

Reliance GIC

OYO Rooms

BOAT

Tata Capital

SBI AMC

Swiggy Limited

Waree Energies

Rapido

Incred Holdings

News Alert